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Background: Fibroblast Growth Factor 18 (FGF18) functions in the development of several tissues, 
including the lung, limb bud, palate, skeleton, central nervous system, and hair follicle. Mice containing a 
germline knockout of Fgf18 (Fgf18-/-) die shortly after birth. Postnatally, FGF18 is being evaluated for 
pathogenic roles in fibrosis and several types of cancer. The specific cell types that express FGF18 have been 
difficult to identify, and the function of FGF18 in postnatal development and tissue homeostasis has been 
hampered by the perinatal lethality of Fgf18 null mice.  
Results: We engineered a floxed allele of Fgf18 (Fgf18flox) that allows conditional gene inactivation and a 
CreERT2 knockin allele (Fgf18CreERT2) that allows the precise identification of cells that express Fgf18 and their 
lineage.  We validated the Fgf18flox allele by targeting it in mesenchymal tissue and primary mesoderm during 
embryonic development, resulting in similar phenotypes to those observed in Fgf18 null mice. We also use the 
Fgf18CreERT2 allele, in combination with a conditional fluorescent reporter to confirm known and identify new 
sites of Fgf18 expression. 
Conclusion: These alleles will be useful to investigate FGF18 function during organogenesis and tissue 
homeostasis, and to target specific cell lineages at embryonic and postnatal time points.  
 
Background 
The Fibroblast Growth Factor (FGF) family consists of 18 signaling proteins that regulate embryonic and 
postnatal development, and in the adult function as homeostatic and tissue repair factors. FGF18 is in the 
FGF8 subfamily, comprised of FGF8, FGF17, and FGF18 (Itoh and Ornitz, 2008; Itoh and Ornitz, 2011; Ornitz 
and Itoh, 2015; Ornitz and Marie, 2015). This family of FGFs activate FGFR4 and the mesenchymal splice 
variants of FGFRs 1, 2, and 3 (Ornitz et al., 1996; Zhang et al., 2006). 
Mice containing a germline knockout of Fgf18 (Fgf18-/-) die shortly after birth. The likely deleterious 
phenotypes include cleft palate, saccular stage lung immaturity, and abnormal nerve terminals in the 
diaphragm (Ito et al., 2018; Liu et al., 2002; Ohbayashi et al., 2002; Usui et al., 2004). During embryonic 
development, Fgf18 primarily signals to mesenchymal tissue in developing bone and cartilage, lung, and brain 
(Hasegawa et al., 2004; Hung et al., 2016; Liu et al., 2002; Liu et al., 2007; Ohbayashi et al., 2002; Usui et al., 
2004). The function of FGF18 in postnatal tissue is poorly understood due to the perinatal lethality of the Fgf18-
/- mouse. 
In neonatal rats and mice, Fgf18 expression increases in the lung during alveologenesis and then returns 
to lower levels in the adult (Chailley-Heu et al., 2005; Franco-Montoya et al., 2011). Cell sorting experiments 















suggest that Fgf18 is expressed in myofibroblasts of the postnatal lung (McGowan and McCoy, 2015). In skin, 
Fgf18 expression is found in inner root sheath cells of the hair follicles where it is thought to maintain stem 
cells in a quiescent state  (Blanpain et al., 2004; Kawano et al., 2005; Kimura-Ueki et al., 2012; Leishman et 
al., 2013). In adult joint tissue, Fgf18 is expressed in the articular surface where it is thought to maintain 
cartilage homeostasis and protect against osteoarthritis (Mori et al., 2014). Fgf18 is also expressed in the 
postnatal growth plate (Karuppaiah et al., 2016; Lazarus et al., 2007). In the postnatal brain, Fgf18 is 
transiently expressed in neurons in the cerebral cortex and hippocampus (Hoshikawa et al., 2002) and in adult 
brain tanycytes lining the ventricular wall (Kaminskas et al., 2019). 
To facilitate functional studies of Fgf18 in specific tissues and at postnatal and adult time points we have 
engineered a floxed allele of Fgf18 (Fgf18flox). Targeting this allele in mesenchymal tissue during embryonic 
development results in similar phenotypes to those observed in Fgf18-/- null mice. To allow the precise 
identification of cells that express Fgf18 and to follow their lineage, we have engineered a knockin CreERT2 
allele, Fgf18CreERT2. Activation of fluorescent reporter alleles in embryonic, neonatal, and adult mice confirm 
known and identify new sites of Fgf18 expression. These studies validate these novel alleles of Fgf18 for future 
functional and lineage studies in mice.  
 
Results & Discussion 
Generation of an Fgf18CreERT2 knockin allele and an Fgf18flox allele. 
We designed a novel multifunctional targeting vector to generate a conditional (eGFP:CreERT2) lineage 
tracing allele and knockout (flox) allele from a single gene-targeting event in embryonic stem cells. The allele 
design was modeled after the design used by the International Mouse Phenotyping Consortium (IMPC) 
“knockout first” conditional allele (Skarnes et al., 2011), in which the splice acceptor (SA) LacZ was replaced 
with CreERT2. 
The targeting vector design for the Fgf18 genomic locus placed a splice acceptor (SA)-eGFP:CreERT2 
fusion gene (Mugford et al., 2008) into the intron located between Fgf18 exons 1B and 1C, along with a PGK-
neo selection cassette (Fig. 1A). The SA contains 875 bp of the En2 intron, the En2 SA, and 40 bp of En2 
exon 2 (Skarnes et al., 2011). The SA sequence is followed by a T2A sequence and a 15 bp linker sequence 
placed in frame with eGFP:CreERT2. Integration of the targeting vector into the genome was validated by 
Southern blot of the 5’ and 3’ ends (Fig. 1B, C).  
We strategically included Frt and LoxP recombination sites in the targeted allele (Fig. 1D) to allow the 















generation of two independent alleles by crossing the parental mouse line to either a germline expressed FLP 
recombinase or a germline expressed Cre recombinase mouse (Fig. 1E, F) (Farley et al., 2000; Hayashi et al., 
2002). This generated a conditional allele, with the critical exon 1C flanked by loxP sites (Fgf18flox) and a 
tamoxifen inducible eGFP:CreERT2 allele driven by the endogenous Fgf18 promoter (Fgf18CreERT2) that can be 
used for lineage tracing. Importantly, the Fgf18CreERT2 allele has exon 1C deleted and is predicted to behave as 
a functional null allele. 
 
Functional testing of the Fgf18flox allele. 
We tested the functionality of the Fgf18flox allele by crossing Fgf18flox/flox mice to Dermo1Cre 
(Twist2tm1.1(cre)Dor) mice to generate Dermo1Cre; Fgf18flox/flox conditional knockout mice. Dermo1Cre targets 
the mesenchymal condensations giving rise to both osteoblast and chondrocyte lineages (Yu et al., 2003). Like 
Fgf18-/- mice, Dermo1Cre; Fgf18flox/flox mice are not viable. Analysis of E18.5 Dermo1Cre; Fgf18flox/flox embryos 
revealed similar phenotypic features to those observed in Fgf18-/- embryos (Fig. 2A) (Liu et al., 2002; 
Ohbayashi et al., 2002). Specifically, Dermo1Cre; Fgf18flox/flox mice show incomplete suture closure of the 
calvaria, deformities in the ribs, a bend in the radius, and bowing of the tibia (Fig. 2B-E). In contrast to Fgf18-/- 
mice, Dermo1Cre; Fgf18flox/flox animals do not have a cleft palate defect (data not shown), suggesting this 
phenotype is due to FGF18 signaling outside of the Dermo1Cre targeted mesenchyme lineage. This further 
suggests that the lethality evident in the Fgf18-/- mice is not solely due to a cleft palate defect. 
To further examine the effects of widespread FGF18 inactivation within the embryonic mesoderm, we 
generated TCre (Tg(T-cre)1Lwd); Fgf18flox/- conditional knockout mice. TCre targets progenitors cells in the 
primitive streak and tailbud (Perantoni et al., 2005). Like Dermo1Cre; Fgf18flox/flox mice, TCre; Fgf18flox/- mice 
were not viable. Analysis of the E18.5 embryos revealed TCre; Fgf18flox/- mice had a distinct hunchbacked 
appearance (kyphosis) and misshapen limbs (Fig. 2H, I; arrows). TCre; Fgf18flox/- phenocopied  Fgf18-/- mice 
(Fig. 2F, G) (Hung et al., 2016; Liu et al., 2002; Ohbayashi et al., 2002). Heterozygous control mice did not 
exhibit skeletal defects (Fig. 2 F, H). Quantification of length of the axis revealed no difference between the 
germline and conditional knockouts, but both were significantly shorter than their littermate controls (Fig. 3J). 
TCre; Fgf18flox/- conditional knockouts also did not have a cleft palate defect (data not shown). This is 
presumably due to absence of TCre expression in the first and second pharyngeal arches from which the 
palate is derived. These data suggest that, upon Cre recombination, the floxed allele described here abolishes 
Fgf18 activity. 
 















Fgf18CreERT2 is a functional null allele. 
To determine whether the Fgf18CreERT2 allele behaves as a functional null allele, heterozygous mice were 
intercrossed, and homozygous mice were examined at P0 (Fig. 3). Fgf18CreERT2/CreERT2 mice resulted in 
perinatal lethality. Phenotypic analysis of Fgf18CreERT2/CreERT2 skeletons displayed abnormalities characteristic of 
Fgf18-/- mice including defects in the jaw, incomplete suture closing of the calvaria, deformities of the ribs, and 
the characteristic bend in the radius (Liu et al., 2002; Liu et al., 2007; Ohbayashi et al., 2002) (Fig. 3A-D). This 
demonstrates that Fgf18CreERT2 behaves as a functional null and suggests it can be crossed to the Fgf18flox 
allele to generate heterozygous CreERT2/flox (Fgf18CreERT2/flox) mice, in which Fgf18CreERT2 can be used to 
conditionally inactivate the Fgf18flox allele. This self-knockout strategy should effectively inactivate Fgf18 in all 
Fgf18-expressing cells and their lineage descendants when mice are exposed to tamoxifen. 
 
Fgf18CreERT2 activity during embryonic development 
To determine the expression of Fgf18CreERT2 and validate its ability to recombine floxed alleles during 
embryogenesis, we compared the endogenous Fgf18 mRNA pattern by whole-mount in situ hybridization 
(WISH) (Fig. 4 A-C) with the GFP fluorescence pattern of the Fgf18 driven eGFP:CreERT2 fusion protein (Fig. 
4 D-F). We then crossed the Fgf18CreERT2/+ allele with a Cre-dependent ROSAtdTomato/+ reporter allele to 
generate Fgf18Lineage mice, administered tamoxifen at similar embryonic time points and assayed for 
recombination mediated tdTomato fluorescence 24 hr later (Fig. 4G-I). 
Expression of Fgf18 at E8.0 has been reported in the somites and the presomitic mesoderm (Maruoka et 
al., 1998). At this stage, weak Fgf18 expression was observed in the allantois and in a few cells within the 
emerging first somite (Fig. 4A). However, the GFP signal in Fgf18CreERT2/+ embryos was undetectable, 
suggesting very low levels of expression (Fig. 4D). After inducing at E7.5 and harvesting at E8.5, Fgf18Lineage 
expressing cells were found in the somites (Fig. 4G) and in a few cells in the mid-hindbrain junction (mhb) and 
allantois (data not shown). 
At E9.5 Fgf18 expression displayed a more widespread pattern. As reported (Maruoka et al., 1998), Fgf18 
mRNA was strongly detected in the somites, mhb, and anterior presomitic mesoderm (apsm). Lower levels 
were detected in the otic pit, trigeminal ganglion, dorsal root ganglia, tailbud, forebrain, and neural tube (Fig. 
4B). Clear GFP signal was observed only in the somites, mhb, and apsm (Fig. 4E). Fgf18Lineage expressing 
cells were observed in the somites and mhb (Fig. 4H). Low levels of tdTomato were seen in the forebrain as 















well as individual recombined cells in a salt-and-pepper pattern in the tailbud and future jaw, consistent with 
incomplete recombination (data not shown). 
At E12.5, Fgf18 mRNA was still present in the somites, brain, and apsm. New sites of expression were 
detected in the future jaw, and in aspects of the limbs (Fig. 4C). Fgf18CreERT2 embryos showed weak GFP 
signal in the somites, the apsm, the limbs, and the jaw (Fig. 4F). Fgf18Lineage expressing cells were extensive in 
the limbs and digits, in the nascent somites, and the jaw (Fig. 4I). tdTomato+ cells were also present in the 
interdigit mesenchyme and in tissues in the back of the embryo, consistent with previously reported sites of 
Fgf18 expression (Maruoka et al., 1998; Mok et al., 2014). These data suggest that the Fgf18CreERT2 allele 
faithfully recapitulates the endogenous expression pattern, however detection of the eGFP:CreERT2 fusion 
protein by native fluorescence is not sensitive enough for lowly expressed tissues or tissues with high 
autofluorescence.  
 
Fgf18CreERT2 lineage during postnatal skeletal development 
Fgf18 is expressed in proliferative zone chondrocytes in 1-week-old postnatal rodents and in articular 
cartilage of adult animals, assayed by qPCR, in situ hybridization, and immunofluorescence (Ellsworth et al., 
2002; Lazarus et al., 2007; Mori et al., 2014). To identify in situ the cells expressing Fgf18CreERT2 in the 
postnatal and adult skeleton, Fgf18Lineage neonatal mice were injected with tamoxifen and then harvested at 
different time points for analysis (Fig. 5 A-C). In neonatal mice, Fgf18Lineage expressing cells were found in the 
periosteum of cortical bone, the articular surface of the synovial joint, synovial tissue, and in cells within the 
perichondrial groove of Ranvier. Endosteal Fgf18Lineage expression was also observed, but less uniformly 
compared to periosteal expression (data not shown). The lineage of these Fgf18Lineage expressing cells was 
traced into adult animals (P56) and displayed a similar pattern to the neonatal animals, demonstrating that 
these cells are maintained. Fgf18Lineage animals induced as adults showed tdTomato+ cells in the periosteum, 
articular cartilage, and cells lining the meniscus (Fig. 5D). 
These studies show that Fgf18CreER is active in adult articular chondrocytes indicating that the Fgf18 gene is 
expressed in this tissue in adult mice and may therefore have a role in maintaining joint tissue homeostasis or 
priming the tissue for injury response. These expression data are consistent with immunostaining for FGF18 in 
rat articular chondrocytes (Mori et al., 2014). Since FGF18 is a secreted growth factor it could act directly on 
chondrocytes at the joint surface and/or it could be secreted into synovial fluid and signal to any of the tissues 
lining the joint space. 
















Fgf18CreERT2 lineage in postnatal visceral organ development 
In  rodent postnatal visceral organ development Fgf18 expression has been observed in the lung (Chailley-
Heu et al., 2005; Franco-Montoya et al., 2011), but its expression in other organs has not been reported. To 
identify cells expressing Fgf18 during postnatal visceral organogenesis, Fgf18Lineage mice were given daily 
tamoxifen doses from postnatal day 5 (P5) to P8 and collected on P9. Fgf18Lineage expressing cells were 
detected in the spleen, lung, liver, and pancreas (Fig. 6). The bladder, kidney, and small intestine were 
analyzed but did not display tdTomato+ cells. In the spleen, tdTomato+ cells were seen in the sub-mesothelial 
connective tissue capsule (Fig. 6A, arrow) as well as sparse cells in the parenchyma. The lung shows the 
greatest amount of tdTomato+ cells, located in the single-cell mesothelium (Fig. 6B, arrow) and many cells in 
the parenchyma (Fig. 6B, arrowhead). Cells in the parenchyma were determined to be predominantly alveolar 
myofibroblasts (data not shown, manuscript in submission). Expression in the liver and pancreas was more 
restricted with tdTomato+ cells located in perivascular regions, likely smooth muscle cells (Fig. 6C, D). These 
results suggest that Fgf18, based on expression, has a functional role in postnatal organogenesis of the 
spleen, lung, liver, and pancreas. 
 
Fgf18CreERT2 lineage in adult visceral organ homeostasis 
In adult murine tissue Fgf18 expression has been reported in the lungs and kidneys at high levels with 
lower-level expression in the heart, testis, spleen, skeletal muscle, and brain (Hu et al., 1998). To identify cells 
expressing Fgf18 during visceral organ homeostasis, adult Fgf18Lineage mice were induced for 1-week with 
tamoxifen chow followed by a 1-week washout before tissue collection. Fgf18Lineage expressing cells were 
detected in the spleen, heart, aorta, lung, liver, kidney, and cardiac valve (Fig. 7). The pancreas, testis, and 
white visceral fat depot were analyzed but did not show any tdTomato+ cells. In the spleen Fgf18Lineage labeled 
cells showed a similar capsule expression pattern as observed in the postnatal animal (Fig. 7A), but exhibited 
additional tdTomato+ cells located in the perivascular region around large vessels (Fig. 7A’). In the aorta, 
tdTomato+ cells were located in the outermost mesenchymal derived interstitial cells (adventitia) of the vascular 
wall (Fig. 7C). In the heart, lung, liver, and kidney, tdTomato+ cells were found, to differing degrees, in visceral 
mesothelial cells (Fig. 7B, D, L, K). The strongest mesothelial expression was seen in the lung followed by the 
liver. Fgf18Lineage cells were found in sparse parenchyma cells in lung and kidney. tdTomato+ cells were 
abundant in cardiac valve interstitial cells (Fig. 7G). Taken together these results indicate that Fgf18CreERT2 is 















able to mark diverse cell types in multiple adult organs under homeostatic conditions. Future work to define the 
fate and function of these cells during injury response should be informative. 
 
Fgf18CreERT2 lineage in the adult brain 
To gain better insight into the expression of Fgf18 and cells derived from them in the brain, adult 
Fgf18Lineage mice were induced for two weeks with tamoxifen chow followed by a 1-week washout before tissue 
collection. Tissue from multiple bregma coordinates was immunolabeled to detect astrocytes (GFAP+) as well 
as Fgf18Lineage expressing cells (Tomato+) (Fig. 8). Fgf18Lineage expressing cells were detected in hypothalamic 
tanycytes and the ependymal lining of the dorsal third ventricle (3V) (Fig. 8F). Fgf18Lineage expressing cells 
were additionally detected in a subset of cortical pial astrocytes (Fig. 8B); in rare neurons in the cerebral cortex 
(Fig. 8C, D); the choroid plexus, and ependymal lining of the dorsal third ventricle (3V) and forth ventricle 
recess (4V) (Fig. 8E, H); pial astrocytes (Fig. 8G); septum (Fig. 8J), and amygdala (not shown). Interestingly, 
Fgf18Lineage expressing cells were also found in the walls of the lateral ventricles. These could be followed 
anteriorly into the olfactory bulbs, where Fgf18Lineage expressing olfactory bulb (OB) neurons were clearly 
evident, reminiscent of neuronal supply to the OB via the rostral migratory stream (Fig. 8J, L-O) (Obernier and 
Alvarez-Buylla, 2019). In these mice, it is likely the long period between initial tamoxifen treatment and tissue 
collection resulted in the Fgf18Lineage expressing cells including both cells expressing Fgf18CreERT2 as well as 
their descendants at the time of harvest. This conclusion is supported by a more restricted number and 
distribution of Fgf18Lineage labeled cells in the hypothalamus of animals pulsed more briefly with tamoxifen and 
harvested acutely (Kaminskas et al., 2019). 
 
Conclusion 
This study demonstrates the generation and validation of two novel alleles targeting the Fgf18 locus that 
will be useful for the investigation of the tissue specific function of the gene (Fgf18flox) and the lineage of its 
expressing cells (Fgf18CreERT2). Using Fgf18flox, it was confirmed that the majority of the skeletal phenotypes of 
Fgf18-/- animals, including deformities of the calvaria, ribs, hindlimb, forelimb, and axis, are dependent on 
Fgf18 expression originating from the mesenchymal compartment. Using Fgf18CreERT2, expression of Fgf18 was 
confirmed in known and identified in new sites in the embryo in multiple organs including the somites and mid-
hindbrain junction; the postnatal and juvenile skeleton; in postnatal and adult visceral organs; and in adult 
brain. These tools will be useful to investigate FGF18 function during organogenesis and tissue homeostasis, 



















All animals were housed in pathogen-free barrier facilities. All studies were performed under a protocol 
approved by the Institutional Animal Care at Washington University in St. Louis (Approval No. 20160013) or in 
accordance with the recommendations in the Guide for Care and Use of Laboratory Animals of the National 
Institutes of Health under a protocol approved by the Animal Care and Usage Committee of NCI-Frederick 
(NIH) (Animal Study Proposal: 17-069). Mice of both sexes were utilized. Mice were maintained on a mixed 
C57BL/6J x 129X1/SvJ or outbred genetic background. Fgf18CreERT2 mice and Fgf18flox were generated in 
house. Fgf18- allele was generated by recombining the Fgf18flox allele in the germline with Sox2-Cre (Hayashi 
et al., 2002). 
All other mouse strains, including, ROSAtdTomato, Dermo1Cre, TCre, Sox2-Cre, and FLPeR have been 
previously described (Farley et al., 2000; Hayashi et al., 2002; Madisen et al., 2010; Perantoni et al., 2005; Yu 
et al., 2003). Postnatal day 0 (P0) was assigned as the day of birth. Embryonic day 0.5 (E0.5) was assigned as 
the day the vaginal plug was found in timed-mating experiments. Adult mice were 8 weeks of age or older. 
 
Genetic crosses 
To generate Fgf18-/- fetuses, TCre+/+; Fgf18-/+ mice were intercrossed. To generate TCre+; Fgf18flox/- mice, 
Fgf18flox/flox females were crossed to TCre+/+; Fgf18-/+ males. Mice were maintained on an outbred background. 
The TCre line has been described previously (Perantoni et al., 2005). To investigate the effectiveness of Cre 
mediated recombination, we generated Fgf18CreERT2/+; ROSAtdTomato/tdTomato males and mated them to females to 
generate experimental litters. This cross was used to assess both GFP signal and Cre-mediated 
recombination. Fgf18CreERT2/+; ROSAtdTomato/+ when exposed to tamoxifen are referred to as Fgf18Lineage mice. 
 
Southern Blot  
Genomic DNA digested with SpeI was screen by DNA analysis with probes designed against the 5’ end 
and generated by PCR amplification (Probe A: Forward, gctgaatatgttcagatcttggctctgtgc; Reverse, 
cacaggtgggtagcagatgcagcatgatac). Genomic DNA digested with NdeI was screen by DNA analysis with probes 















designed against the 3’ end and generated by PCR amplification (Probe B: Forward, 
tgtgagtattctgaatgactgtggtcccac; Reverse, gacagccagctcatgtgctcatgatgtctg). 
 
Sample Preparation: Skeleton 
Skeletons were prepared as described previously (Colvin et al., 1996; Nagy et al., 2003). For postnatal day 
P0 skeletal preparations, carcasses were skinned and eviscerated, and then soaked in acetone for 12–24 hr, 
cleared in 2% KOH (12–24 h), stained with alizarin red S (Millipore-Sigma, 58005) and alcian blue (Millipore-
Sigma, 74240) for 12–24 h, cleared in 1% KOH/20% glycerol, and stored in glycerol. For embryo skeleton 
preparations, fetuses were skinned and eviscerated, stained with alizarin red S and alcian blue (12–24 hr), 
cleared in 1%KOH/20% glycerol, and stored in glycerol. 
 
Sample preparation: visceral organs 
At designated collection times, mice were sacrificed with an overdose of a cocktail containing ketamine and 
xylazine, perfused with PBS through the right ventricle, and indicated organs were fixed with submersion in 
10% neutral buffered formalin (VWR International, Radnor, Pennsylvania; 89370). Lungs were fixed via 
intratracheal inflation at a pressure of 20 cm H2O of 10% neutral buffered formalin. Organs were fixed 
overnight at 4°C with gentle agitation. Samples were washed twice in PBS, cryoprotected in 15% sucrose in 
PBS overnight at 4°C with gentle agitation, and then 30% sucrose overnight at 4°C with gentle agitation. 
Organs were patted dry, equilibrated in Tissue-Tek® O.C.T. compound (VWR, 4583) for 20 min, embedded, 
and frozen on dry ice. Frozen sections were cut at 6 µm with a cryostat, dried at room temperature, and stored 
at -80°C until use. Slides were warmed for 10 min at room temperature and washed in PBS before being 
permeabilized in PBS + 0.5% Triton X-100 (Sigma, X-100) for 15 min. Slides were washed 3x in PBS, mounted 
in Vectashield® antifade mounting medium with DAPI (ThermoFisher, NC9524612), sealed with nail polish, 
and stored at 4°C until imaged. 
 
 Tamoxifen administration 
For embryonic experiments tamoxifen (80 mg/kg) and progesterone (40 mg/kg) were co-injected 
intraperitoneally (IP) into pregnant dams 24 hours before collection of embryos. To prepare, 100 mg of 
tamoxifen (Millipore-Sigma, T5648) was dissolved in 5 ml of corn oil (Millipore-Sigma C8267) to which was 
added 5 ml of 50 mg/ml progesterone dissolved in sesame oil (Watson Pharma Inc., Parsippany, New Jersey; 















NDC 0591-3128-79). This was then sterilized through a 0.22 µm filter and stored at 4qC before use. For early 
neonatal experiments, tamoxifen was administered by IP injection at a dose of 150 µg on four sequential days 
beginning at postnatal day 5 (P5). Tamoxifen was prepared at a concentration of 20 µg/µl dissolved in corn oil 
or sunflower seed oil for injection. For juvenile and adult experiments tamoxifen was administered by chow 
(400 mg/kg tamoxifen citrate) (Envigo, Huntingdon, United Kingdom; TD.130860) for 10-14 days (juvenile), 7 
days (adult visceral organs), or 14 days (adult skeleton). Tamoxifen was administered by chow in longer-term 
juvenile and adult experiments to avoid unnecessary injections (Whitfield et al., 2015). IP injections were 
unavoidable in embryonic and neonatal experiments. Differences in recombination efficiency between the two 
methods of tamoxifen administration were not directly assessed.  
 
In situ hybridization 
Whole mount in situ hybridization was performed according to published protocols (Wilkinson and Nieto, 
1993). The Fgf18 probe was generated from a previously published plasmid linearized with SacII and 
transcribed using SP6 polymerase (Xu et al., 2000). Prolonged development of the stain was required for E8.0 
embryos. Samples at E9.5 and E12.5 were cleared in 50% glycerol:PBS for several days prior to imaging.   
 
Imaging 
With the exception of adult brain analysis, eGFP and tdTomato were detected by native fluorescence. 
Images are representative of at least 2 mice. For brain analysis, serial 60 Pm thick coronal vibratome sections 
were generated and immunolabeled with anti-Tomato dsred as well as anti-Glial Fibrillary Acidic Protein 
(GFAP) antibodies, performed according to published protocols (Haan et al., 2013; Kaminskas et al., 2019). 
Immunolabelled sections were counterstained with Hoechst stain. Atlas images are from the Mouse Brain 
Library (http://www.mbl.org/mbl_main/atlas.html (Williams, 2000). 
Fluorescent microscopy of slides was performed using either Zeiss LSM-700 Confocal Microscope Carl 
Zeiss AG, Oberkochen, Germany) (single plane) and or on a Zeiss Axio Imager M2 with respective ZEN 
software. Differential interference contrast microscopy of slides was performed using Zeiss Axio Imager M2. 
Whole-mount brightfield images were performed using an Olympus SZX12 Stereozoom microscope (Olympus 
Corporation, Tokyo, Japan) or Olympus MVX10 microscope. Whole mount fluorescent images were performed 
using an Olympus MVX10 microscope excited using an X-Cite Turbo XT600-T fluorescence light source 
(Excelitas Technologies Corp, Waltham, Massachusetts) at 475 nm and 575 nm wavelengths. Images were 















processed using either Canvas X (Canvas GFX), ImageJ, or Photoshop (Adobe Inc., San Jose, California). 
 
Measurements, Statistical Analysis, and Plotting  
Length of the axis was measured from the atlas to the tip of the tail. Data were found to be normally 
distributed by a Shapiro-Wilk test. Significant differences in mean values between two sets of data were 
calculated by using an unpaired t-test. A P value of less than 0.05 was considered significant. Sample size (n) 
represents the number of animals. Data are represented as mean ± standard deviation. * indicates p < 0.05. All 
figures were made in Canvas X. Plots were generated in Prism 7 (GraphPad Software, San Diego, CA). 
 
Acknowledgements 
We thank W. Lewis and E. Truffer for animal caretaking and M. Brown for technical assistance. 
Author Contributions 
Conceptualization, I.H.H., D.M.O.; Methodology, M.L., D.M.O.; Formal Analysis, A.S.H., M.B., C.S., E.P.S., 
K.K., M.K.H.; Investigation, A.S.H., M.B., E.P.S., K.K., C.S., M.K.H.; Resources, I.H.H., M.L. D.M.O.; Writing – 
Original Draft, A.S.H., M.B., M.L., D.M.O.; Writing – Review & Editing, A.S.H., D.M.O; Supervision, M.L., 
D.M.O.; Funding Acquisition, D.M.O., M.L. 
Additional information 
Competing interests 
The authors declare no competing interests.  
















Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. 2004. Self-Renewal, Multipotency, and the Existence 
of Two Cell Populations within an Epithelial Stem Cell Niche. Cell 118:635–648. 
Chailley-Heu B, Boucherat O, Barlier-Mur A-M, Bourbon JR. 2005. FGF-18 is upregulated in the postnatal rat 
lung and enhances elastogenesis in myofibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 288:L43-
51. 
Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. 1996. Skeletal overgrowth and deafness in mice 
lacking fibroblast growth factor receptor 3. Nature Genetics 12:390. 
Ellsworth JL, Berry J, Bukowski T, Claus J, Feldhaus A, Holderman S, Holdren MS, Lum KD, Moore EE, 
Raymond F, Ren H, Shea P, Sprecher C, Storey H, Thompson DL, Waggie K, Yao L, Fernandes RJ, 
Eyre DR, Hughes SD. 2002. Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and 
their progenitors. Osteoarthritis and Cartilage 10:308–320. 
Farley FW, Soriano P, Steffen LS, Dymecki SM. 2000. Widespread recombinase expression using FLPeR 
(Flipper) mice. genesis 28:106–110. 
Franco-Montoya M-L, Boucherat O, Thibault C, Chailley-Heu B, Incitti R, Delacourt C, Bourbon JR. 2011. 
Profiling target genes of FGF18 in the postnatal mouse lung: possible relevance for alveolar 
development. Physiol Genomics 43:1226–1240. 
Haan N, Goodman T, Najdi-Samiei A, Stratford CM, Rice R, Agha EE, Bellusci S, Hajihosseini MK. 2013. 
Fgf10-Expressing Tanycytes Add New Neurons to the Appetite/Energy-Balance Regulating Centers of 
the Postnatal and Adult Hypothalamus. J. Neurosci. 33:6170–6180. 
Hasegawa H, Ashigaki S, Takamatsu M, Suzuki-Migishima R, Ohbayashi N, Itoh N, Takada S, Tanabe Y. 
2004. Laminar Patterning in the Developing Neocortex by Temporally Coordinated Fibroblast Growth 
Factor Signaling. J. Neurosci. 24:8711–8719. 
Hayashi S, Lewis P, Pevny L, McMahon AP. 2002. Efficient gene modulation in mouse epiblast using a 
Sox2Cre transgenic mouse strain. Mechanisms of Development 119:S97–S101. 
Hoshikawa M, Yonamine A, Konishi M, Itoh N. 2002. FGF-18 is a neuron-derived glial cell growth factor 
expressed in the rat brain during early postnatal development. Molecular Brain Research 105:60–66. 
Hu MC-T, Qiu WR, Wang Y, Hill D, Ring BD, Scully S, Bolon B, DeRose M, Luethy R, Simonet WS, Arakawa 
T, Danilenko DM. 1998. FGF-18, a Novel Member of the Fibroblast Growth Factor Family, Stimulates 
Hepatic and Intestinal Proliferation. Molecular and Cellular Biology 18:6063–6074. 
Hung IH, Schoenwolf GC, Lewandoski M, Ornitz DM. 2016. A combined series of Fgf9 and Fgf18 mutant 
alleles identifies unique and redundant roles in skeletal development. Dev. Biol. 411:72–84. 
Ito K, Ohkawara B, Yagi H, Nakashima H, Tsushima M, Ota K, Konishi H, Masuda A, Imagama S, Kiyama H, 
Ishiguro N, Ohno K. 2018. Lack of Fgf18 causes abnormal clustering of motor nerve terminals at the 
neuromuscular junction with reduced acetylcholine receptor clusters. Scientific Reports 8. 
http://www.nature.com/articles/s41598-017-18753-5. 
Itoh N, Ornitz DM. 2011. Fibroblast growth factors: from molecular evolution to roles in development, 
metabolism and disease. Journal of Biochemistry 149:121–130. 
Itoh N, Ornitz DM. 2008. Functional evolutionary history of the mouse Fgf gene family. Developmental 
Dynamics 237:18–27. 
Kaminskas B, Goodman T, Hagan A, Bellusci S, Ornitz DM, Hajihosseini MK. 2019. Characterization of 
endogenous players in Fibroblast Growth Factor-regulated functions of hypothalamic tanycytes and 
energy-balance nuclei. Journal of Neuroendocrinology. 
https://onlinelibrary.wiley.com/doi/abs/10.1111/jne.12750. 















Karuppaiah K, Yu K, Lim J, Chen J, Smith C, Long F, Ornitz DM. 2016. FGF signaling in the osteoprogenitor 
lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth. 
Development 143:1811–1822. 
Kawano M, Komi-Kuramochi A, Asada M, Suzuki M, Oki J, Jiang J, Imamura T. 2005. Comprehensive Analysis 
of FGF and FGFR Expression in Skin: FGF18 Is Highly Expressed in Hair Follicles and Capable of 
Inducing Anagen from Telogen Stage Hair Follicles. Journal of Investigative Dermatology 124:877–885. 
Kimura-Ueki M, Oda Y, Oki J, Komi-Kuramochi A, Honda E, Asada M, Suzuki M, Imamura T. 2012. Hair Cycle 
Resting Phase Is Regulated by Cyclic Epithelial FGF18 Signaling. Journal of Investigative Dermatology 
132:1338–1345. 
Lazarus JE, Hegde A, Andrade AC, Nilsson O, Baron J. 2007. Fibroblast growth factor expression in the 
postnatal growth plate. Bone 40:577–586. 
Leishman E, Howard JM, Garcia GE, Miao Q, Ku AT, Dekker JD, Tucker H, Nguyen H. 2013. Foxp1 maintains 
hair follicle stem cell quiescence through regulation of Fgf18. Development 140:3809–3818. 
Liu Z, Lavine KJ, Hung IH, Ornitz DM. 2007. FGF18 is required for early chondrocyte proliferation, hypertrophy 
and vascular invasion of the growth plate. Developmental Biology 302:80–91. 
Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast 
growth factor 18. Genes Dev. 16:859–869. 
Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones 
AR, Lein ES, Zeng H. 2010. A robust and high-throughput Cre reporting and characterization system 
for the whole mouse brain. Nature Neuroscience 13:133–140. 
Maruoka Y, Ohbayashi N, Hoshikawa M, Itoh N, Hogan BLM, Furuta Y. 1998. Comparison of the expression of 
three highly related genes, Fgf8, Fgf17 and Fgf18, in the mouse embryo. Mechanisms of Development 
74:175–177. 
McGowan SE, McCoy DM. 2015. Fibroblast growth factor signaling in myofibroblasts differs from lipofibroblasts 
during alveolar septation in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 309:L463-474. 
Mok GF, Cardenas R, Anderton H, Campbell KHS, Sweetman D. 2014. Interactions between FGF18 and 
retinoic acid regulate differentiation of chick embryo limb myoblasts. Developmental Biology 396:214–
223. 
Mori Y, Saito T, Chang SH, Kobayashi H, Ladel CH, Guehring H, Chung U, Kawaguchi H. 2014. Identification 
of Fibroblast Growth Factor-18 as a Molecule to Protect Adult Articular Cartilage by Gene Expression 
Profiling. J. Biol. Chem. 289:10192–10200. 
Mugford JW, Sipilä P, McMahon JA, McMahon AP. 2008. Osr1 expression demarcates a multi-potent 
population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent 
nephron progenitor compartment within the mammalian kidney. Developmental Biology 324:88–98. 
Nagy A, Gertsenstein M, Vintersten K, Behringer R. 2003. Manipulating the Mouse Embryo: A Laboratory 
Manual 3rd ed. University of Michigan: Cold Spring Harbor Laboratory Press. 
Obernier K, Alvarez-Buylla A. 2019. Neural stem cells: origin, heterogeneity and regulation in the adult 
mammalian brain. Development 146:dev156059. 
Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. 2002. FGF18 is required for 
normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 
16:870–879. 
Ornitz DM, Itoh N. 2015. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol 
4:215–266. 
Ornitz DM, Marie PJ. 2015. Fibroblast growth factor signaling in skeletal development and disease. Genes 
Dev. 29:1463–1486. 















Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. 1996. Receptor 
Specificity of the Fibroblast Growth Factor Family. J. Biol. Chem. 271:15292–15297. 
Perantoni AO, Timofeeva O, Naillat F, Richman C, Pajni-Underwood S, Wilson C, Vainio S, Dove LF, 
Lewandoski M. 2005. Inactivation of FGF8 in early mesoderm reveals an essential role in kidney 
development. Development 132:3859–3871. 
Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, Mujica AO, Thomas M, Harrow J, Cox T, 
Jackson D, Severin J, Biggs P, Fu J, Nefedov M, de Jong PJ, Stewart AF, Bradley A. 2011. A 
conditional knockout resource for the genome-wide study of mouse gene function. Nature 474:337–
342. 
Usui H, Shibayama M, Ohbayashi N, Konishi M, Takada S, Itoh N. 2004. Fgf18 is required for embryonic lung 
alveolar development. Biochemical and Biophysical Research Communications 322:887–892. 
Whitfield J, Littlewood T, Soucek L. 2015. Tamoxifen administration to mice. Cold Spring Harbor Laboratory 
Press. 
Wilkinson DG, Nieto MA. 1993. [22] Detection of messenger RNA by in Situ hybridization to tissue sections 
and whole mounts. In: . Methods in Enzymology. Academic Press. Guide to Techniques in Mouse 
Development, Vol. 225, pp. 361–373. 
http://www.sciencedirect.com/science/article/pii/007668799325025W. 
Williams R. 2000. Mapping genes that modulate mouse brain development: a quantitative genetic approach. 
In: . Mouse Brain Development (Goffinet AF, Rakic P, eds). Springer, New York, pp. 21–49. 
Xu J, Liu Z, Ornitz DM. 2000. Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and 
differentiation of midline cerebellar structures. Development 127:1833–1843. 
Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003. Conditional inactivation of FGF 
receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone 
growth. Development 130:3063–3074. 
Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. 2006. Receptor specificity of the 
fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281:15694–15700. 
  

















Generation and validation of the Fgf18CreERT2 and Fgf18flox mouse lines. A: Scheme displaying targeting vector 
design and insertion into the Fgf18 genomic locus. B, C: Southern blot analysis of the Fgf18 targeted allele, 
with DNA digested with SpeI (left) or NdeI (right) in WT and het animals. Probes were amplified by PCR from 
indicated regions. D: Scheme of the successfully inserted intermediate targeted allele. E, F: Scheme 
displaying generation of a conditional allele (Fgf18flox; E) and a tamoxifen-inducible eGFP:CreERT2 lineage 
allele (Fgf18CreERT2, F) by crossing the targeted allele to germline expressed FLP recombinase and CRE 
recombinase, respectively. Pink arrows indicate LoxP sites; Red bars indicate FRT sites; Green bars indicate 
SA-GFP:CreERT2-pA cassette; Blue bars indicate PGK-neo-pA cassette. WT=wild type; Het=Fgf18Targeted allele/+ 
 
Figure 2 
Recapitulation of known skeletal phenotypes upon removal of Fgf18 using the Fgf18flox allele. Alizarin red and 
Alcian blue stained whole skeleton of E18.5 mice following mesenchyme specific Fgf18 inactivation with 
Dermo1Cre (A-E) or TCre (F-I). A-E: Top, Fgf18flox/flox controls; Bottom, Dermo1Cre; Fgf18flox/flox conditional 
knockouts.  Skeletal defects are seen in (A) whole skeleton, (B) calvaria, (C) ribs, (D) forelimb, and (E) 
hindlimb. Arrows indicate a characteristic bend in the radius and bowed hindlimb zeugopods. F, H: controls, 
(TCre; Fgf18-/+, TCre; Fgf18flox/+, respectively), G: homozygous Fgf18 knockout (TCre; Fgf18-/-), I: mesenchyme 
specific inactivation of Fgf18 (TCre; Fgf18flox/-). Arrows indicate kyphosis, bend in the radius, and bowed 
hindlimb zeugopods. J: Quantification of the length of the axial skeleton in TCre; Fgf18-/+, TCre; Fgf18-/-, TCre; 
Fgf18flox/+, and TCre; Fgf18flox/- animals. Student’s t-test, * p< 0.05. Error bars, mean ± SD. n=5 (TCre; Fgf18-/+, 
TCre; Fgf18-/-), n=3 (TCre; Fgf18flox/+), n=6 (TCre; Fgf18flox/-). 
 
Figure 3 
Validation that Fgf18CreERT2 behaves as a functional null allele. A-D, Alizarin red and Alcian blue stained whole 
skeleton of P0 Fgf18CreERT2/CreERT2 and control (Fgf18CreERT2/+) mice showing defects in (A) jaw, (B) calvaria, (C) 
ribs, and (D) limbs. Arrow indicates a characteristic bend in the radius. 
 
















Fgf18CreERT2 expression in during embryogenesis. A-C: Whole-mount in situ hybridization (WISH) for Fgf18 
mRNA in E8.0 (A), E9.5 (B), and E12.5 (C) wild type embryos. D-F: Whole mount eGFP fluorescence in E8.0 
(D), E9.5 (E), and E12.5 (F) Fgf18CreERT2/+ embryos. Note: The Fgf18CreERT2 allele contains an eGFP fused 
upstream of CreERT2. G-I: Whole mount tdTomato fluorescence of mice induced 24 hr before collection at E8.5 
(G), E10.5 (H), and E13.5 (I) in Fgf18CreERT2/+; ROSAtdTomato/+ embryos. All embryos are shown laterally and are 
of the stage indicated. Arrows and brackets indicate localized expression. a, allantois; apsm, anterior 
presomitic mesoderm; dc, digit condensation; dr, digit ray; drg, dorsal root ganglion; fb, forebrain; fe, femur; lc, 
Limb paddle condensation; lj, lower jaw; mhb, mid-hindbrain; nt, neural tube; op, otic pit; s, somite or somites; 
tb, tailbud; tg, trigeminal ganglion. 
 
Figure 5 
Fgf18CreERT2 expression in skeletal tissue. A-C: Fgf18CreERT2/+; ROSAtdTomato/+ lineage mice were injected with 
tamoxifen daily from P5 to P8 and were collected at P9 (A-A’’), P21 (B, B’), or P56 (C, C’) and imaged for 
tdTomato epifluorescence and histology using differential interference contrast (DIC) microscopy. tdTomato 
epifluorescence was observed in the periosteum (A, B, C), articular surface (A’, C’), meniscus (A’’), and the 
groove of Ranvier (B’, asterisk). D: Fgf18CreERT2/+; ROSAtdTomato/+ lineage mice were given tamoxifen chow at 8 
weeks of age for 14 days and collected at 12 weeks of age. tdTomato epifluorescence and DIC (grey) 
microscopy showing tdTomato+ cells in the periosteum (D) and articular surface (D’). Arrow indicates 
tdTomato+ cells in the periosteum. Arrowhead indicates tdTomato+ cells at the articular surface. ac, articular 
chondrocytes; bm, bone marrow; ct, cortical bone; gp, growth plate; m, meniscus; mu, muscle; p, periosteum; 
sb, subchondral bone; s, synovium; tb, trabecular bone. * indicates groove of Ranvier. Scale bar, 100 µm. 
 
Figure 6 
Fgf18CreERT2 expression in postnatal visceral organs. A-D:  Fgf18CreERT2/+; ROSAtdTomato/+ mice were injected with 
tamoxifen daily from P5 to P8 and were collected at P9. tdTomato+ expressing cells include: (A) splenic 
capsule (arrow); (B) pulmonary mesothelial cells (arrow) and alveolar mesenchyme (arrowhead); (C) liver and 
(D) pancreas perivascular cells (arrows). Bd, bile duct; pv, portal vein. Dapi (Blue). Scale bar, 100 µm. 

















Fgf18CreERT2 expression in adult visceral organs. A-G: Fgf18CreERT2/+; ROSAtdTomato/+ mice were given tamoxifen 
chow at 8 weeks of age for 7 days and collected at 10 weeks of age. tdTomato+ expressing cells include: (A, 
A’) splenic capsule (arrow) and perivascular (arrowhead) cells; (B) select epicardial cells (arrow); (C) aorta 
interstitial cells in the vascular wall (arrow); (D) pulmonary mesothelial (arrow) and alveolar interstitial cells 
(arrowhead); (E) hepatic mesothelial cells (arrow); (F) kidney mesothelial cells (arrow) and occasional epithelial 
tubule cells (arrowhead); (G) cardiac valve interstitial cells. Dapi (Blue). Scale bar, 100 µm. 
 
Figure 8 
Fgf18CreERT2 expressing cells and their putative descendants in the adult brain. Fgf18CreERT2/+; ROSAtdTomato/+ 
mice were given tamoxifen chow at 9 weeks of age for two weeks and collected at 12 weeks of age. A, I, K: 
Photomicrographs from brain atlases to aid regional visualization. B-H, J, L-O: tdTomato+ expressing cells 
include: GFAP+ astrocytes of the Glia limitans (B-B’’’); rare non-pyramidal (C) and pyramidal cortical neurons 
(D); ventricular ependymal cells, adjacent to the medial habenula (E), with no expression in the hippocampus; 
hypothalamic tanycytes and sparse ependymal cells of the third ventricle (3v) wall (F); pair of GFAP+ pial 
astrocytes (G-G’’); strong and specific expression in the choroid plexus of the forth ventricle’s (4v) lateral 
recess (H), near the cerebellum; medial and lateral walls of the lateral ventricles and rare septal neurons (J, 
J’), shown in hemisection; anterior olfactory bulbs (L, L’), near rostral migratory stream cells; scattered 
neurons in the anterior olfactory cortex (M-O). Arrows and arrow heads in (M, N) indicate tdTomato+ neurons 
and their neurite trajectory. Lines indicate structures. Scale bars: 100 µm in B, C, D, E, F, J and L; 50 µm in B’, 
G and L’,: 25 µm in G’ and M-O. v, ventricle; h, hippocampus; cp, choroid plexus; m.e., median eminence; hb, 
habenula. Atlas images are from the Mouse Brain Library (http://www.mbl.org/mbl_main/atlas.html). 






















































































































































































This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
